Luigi Mangione to mount psychiatric defense in UnitedHealthcare CEO murder trial

Luigi Mangione, the man charged with murder in the December 2024 shooting of UnitedHealthcare CEO Brian Thompson, intends to pursue a psychiatric defense at his upcoming state trial, Manhattan Judge Gregory Carro announced on June 17, 2026.

The defense strategy

Mangione's lawyers will argue that their client was in a state of "extreme emotional disturbance" when he killed Thompson, a legal claim that, if accepted by the jury, could reduce a murder conviction to manslaughter. Under New York law, such a downgrade carries a maximum sentence of 25 years, compared with a potential life term for murder. The defense differs from an insanity plea: Mangione would effectively admit to the act while asserting impaired judgment, and he would not be sent to a psychiatric facility unless the jury opts for treatment over incarceration.

This is a strategic choice on his part to limit his exposure on conviction, and while legally viable, I think factually he has a high hurdle to convince a jury.

Judge Carro disclosed the defense strategy two weeks after a sealed hearing and ordered Mangione's attorneys to provide prosecutors with detailed information about the alleged psychological condition by Thursday, June 18. He warned that "nothing is going to be a surprise" and that the defense could be barred if they fail to disclose specifics.

The crime and evidence

The killing took place on December 4, 2024, as Thompson, 50, walked to a Manhattan hotel for an investor conference. Surveillance video captured a masked assailant shooting him from behind. Police found the words "delay," "deny," and "depose" inscribed on ammunition at the scene, a phrase linked to insurer tactics for denying claims. After a five-day manhunt, Mangione was arrested in Altoona, Pennsylvania. Authorities recovered a 3D-printed pistol matching the murder weapon, a silencer, fake identification, and a notebook in which Mangione expressed a desire to "wack" a health insurance executive and railed against the "deadly, greed fueled health insurance cartel."

Legal hurdles

Legal experts note that the extreme emotional disturbance defense faces significant obstacles given the evidence of planning and Mangione's composed demeanor. Former Manhattan prosecutor Gary Galperin said juries have rejected the argument in cases where defendants engaged in premeditation and maintained a calm, careful approach. The defense has succeeded, however, when defendants acted under overwhelming passion or in response to severe trauma. Mangione, who has pleaded not guilty to state charges of murder, weapons possession, and forgery, also faces a federal trial on stalking charges beginning October 13. In January, a federal judge dismissed murder and weapons charges in that case on technical grounds, eliminating the possibility of the death penalty.

It's the same trial twice. One plus one is two. Double jeopardy by any commonsense definition.

Public reaction and context

The brazen killing shocked the United States and reignited widespread anger at the health insurance industry. Some Americans even celebrated Mangione as an avenger against a system they see as parasitic. The case arrives amid long-standing frustration with high healthcare costs and insurers' claim-denial practices.

Key dates in the case

The state trial is set to begin September 8, 2026. Mangione, an Ivy League graduate from a wealthy Maryland family, reportedly suffered from chronic back pain, a detail his lawyers may cite as part of the emotional disturbance narrative.